Chiesi Posts Higher OTC Sales As It Makes Leadership Changes
Italy's Chiesi reported special care and consumer healthcare unit sales up by 20% in the first half as it named Alessandro Chiesi as its new chair.
You may also be interested in...
A round-up of the latest European consumer health industry appointments: Perrigo makes changes to DACH management; Chiesi appoints Giuseppe Accogli as CEO; Haleon adds Pfizer's David Denton to its board; and EMA's Committee on Herbal Medicinal Products re-elects Emiel Van Galen as its chair.
Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.
France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.